| 标题 |
Safety, Biodistribution, and Dosimetry of FAP and Integrin αvβ3 Dual-Targeting Radioligand 177Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas |
| 网址 | |
| DOI | |
| 其它 |
Jialin Xiang, Xuejun Wen, Rongxi Wang, Jiarou Wang, Xingtong Peng, Yanwei Wang, Naixin Liang, Dongyan Cao, Xiaoyuan Chen, Zhaohui Zhu and Jingjing Zhang Journal of Nuclear Medicine August 2026, jnumed.126.272007 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)